Aeglea BioTherapeutics, Inc.
Methods For Production Of Human Recombinant Arginase 1 And Uses Thereof
Last updated:
Abstract:
Described are methods for producing recombinant Arginase, such as PEGylated, cobalt-substituted recombinant human Arginase 1. Also described are pharmaceutical compositions comprising such recombinant Arginase, as well as methods of treatment and uses of such recombinant Arginase.
Status:
Application
Type:
Utility
Filling date:
28 Aug 2020
Issue date:
24 Jun 2021